Author

Raju Sunagar

Albany Medical Center - Cited by 720 - Francisella tularensis - Vaccine development - Microbial pathogenesis - MRSA

Biography

Dr. Raju Sunagr is an senior scientist working at Ella Foundation, Hyderabad. Currently involved in development of live attenuated vaccines and diagnostics for intercellular bacterial pathogens. Also exploring bacteriophage derived lytic enzymes as an novel antimicrobials to treat MDR bacterial pathogens.Experienced Postdoctoral Fellow with a demonstrated history of working in various vaccine development programs. Familiar in mucosal immunology, host immune response to various pathogens. Current research focused on next generation vaccine designing.
Title
Cited by
Year
Trends in therapeutic and prevention strategies for management of bovine mastitis: an overview
JG Tiwari, C Babra, H Tiwari, V Williams, S De Wet, J Gibson, A Paxman, ...Journal of Vaccines & Vaccination 4 (1), 1-11, 2013201
112
2013
Bacterial protein toll-like-receptor agonists: a novel perspective on vaccine adjuvants
S Kumar, R Sunagar, E GosselinFrontiers in immunology 10, 1144, 2019201
79
2019
Aminoglycoside-Resistance Mechanisms in Multidrug-Resistant Staphylococcus aureus Clinical Isolates
R Kelmani Chandrakanth, S Raju, SA PatilCurrent Microbiology 56, 558-562, 2008200
75
2008
Bacteriophage therapy for Staphylococcus aureus bacteremia in streptozotocin-induced diabetic mice
R Sunagar, SA Patil, RK ChandrakanthResearch in microbiology 161 (10), 854-860, 2010201
71
2010
The persistence of biofilm-associated antibiotic resistance of Staphylococcus aureus isolated from clinical bovine mastitis cases in Australia
C Babra, JG Tiwari, G Pier, TH Thein, R Sunagar, S Sundareshan, ...Folia microbiologica 58, 469-474, 2013201
50
2013
Tularemia vaccine development: paralysis or progress?
R Sunagar, S Kumar, BJ Franz, EJ GosselinVaccine: development and therapy, 9-23, 2016201
47
2016
Prevalence and genotype distribution of methicillin-resistant Staphylococcus aureus (MRSA) in India
R Sunagar, NR Hegde, GJ Archana, AY Sinha, K Nagamani, S IsloorJournal of Global Antimicrobial Resistance 7, 46-52, 2016201
43
2016
Human methicillin‐sensitive Staphylococcus aureus biofilms: potential associations with antibiotic resistance persistence and surface polysaccharide antigens
C Babra, J Tiwari, P Costantino, R Sunagar, S Isloor, N Hegde, T MukkurJournal of basic microbiology 54 (7), 721-728, 2014201
25
2014
24
2017
Biofilm formation by multidrug resistant Enterococcus faecalis (MDEF) originated from clinical samples.
AK Oli, S Raju, S Nagaveni, RK ChandrakanthJournal of Microbiology and Biotechnology Research 2 (2), 284-288, 20101
22
2012
Differentiation of Staphylococcus aureus and Staphylococcus epidermidis by PCR for the fibrinogen binding protein gene
R Sunagar, SN Deore, PV Deshpande, A Rizwan, AD Sannejal, ...Journal of dairy science 96 (5), 2857-2865, 131
20
2013
Prevalence of multidrug-resistant Staphylococcus aureus in diabetics clinical samples
S Raju, AK Oli, SA Patil, R Kelmani ChandrakanthWorld Journal of Microbiology and Biotechnology 26, 171-176, 2010201
19
2010
Evaluation of an outbred mouse model for Francisella tularensis vaccine development and testing
R Sunagar, S Kumar, P Namjoshi, SJ Rosa, KRO Hazlett, EJ GosselinPloS one 13 (12), e0207587, 2018201
14
2018
Typing of Staphylococcus aureus isolated from bovine mastitis cases in Australia and India
J Gogoi‐Tiwari, C Babra Waryah, R Sunagar, HB Veeresh, ...Australian Veterinary Journal 93 (8), 278-282, 2015201
14
2015
Increase in cell size and acid tolerance response in a stepwise-adapted methicillin resistant Staphylococcus aureus mutant
S Raju, G Rao, SA Patil, CR KelmaniWorld Journal of Microbiology and Biotechnology 23, 1227-1232, 2007200
13
2007
Preclinical testing of a vaccine candidate against tularemia
RV Suresh, Z Ma, R Sunagar, V Bhatty, S Banik, SV Catlett, EJ Gosselin, ...PLoS One (4), e0124326, 2015201
10
2015
Vaccination evokes gender-dependent protection against tularemia infection in C57BL/6Tac mice
R Sunagar, S Kumar, BJ Franz, EJ GosselinVaccine 34 (29), 3396-3404, 2016201
10
2016
Host factor Ebp1 inhibits rinderpest virus transcription in vivo
M Gopinath, S Raju, A Honda, MS ShailaArchives of virology 155, 455-462, 2010201
8
2010
Downmodulation of Vaccine-Induced Immunity and Protection against the Intracellular Bacterium Francisella tularensis by the Inhibitory Receptor FcγRIIB
BJ Franz, Y Li, C Bitsaktsis, BV Iglesias, G Pham, R Sunagar, S Kumar, ...Journal of immunology research 2015, 2015201
7
2015